发明名称 |
Preparation for vaccination, vaccination method and use of a vaccination preparation |
摘要 |
The present invention relates to a pharmaceutical preparation, comprising at least one Toll-like receptor ligand and at least one peptide. The invention also relates to the use of such a pharmaceutical preparation and to a vaccination method. |
申请公布号 |
US9017654(B2) |
申请公布日期 |
2015.04.28 |
申请号 |
US200511664817 |
申请日期 |
2005.10.06 |
申请人 |
Johannes-Gutenberg-Universitaet Mainz |
发明人 |
Schild Hansjoerg;Warger Tobias;Radsak Markus;Rechtsteiner Gerd |
分类号 |
A61K38/19;A61K39/39;A61K45/00;A61K39/00;A61P37/02 |
主分类号 |
A61K38/19 |
代理机构 |
Abel Law Group, LLP |
代理人 |
Abel Law Group, LLP |
主权项 |
1. A pharmaceutical preparation which comprises from 0.1% to 10% by weight of (a) at least one Toll-like receptor ligand selected from TLR7 ligands, from 0.01% to 30% by weight of (b) at least one peptide selected from (i) major histocompatibility complex class I ligands, (ii) major histocompatibility complex class II ligands, and (iii) peptides which comprise one or more of these histocompatibility complex ligands and are capable of being presented by at least one of a MHC class I molecule and a MHC class II molecule, and from 0.1% to 99.9% by weight of (c) one or more substances selected from carriers, adjuvants and additives, in each case based on a total weight of the preparation; wherein said pharmaceutical preparation elicits increased T cell mediated immune response compared to peptide (b) alone. |
地址 |
Mainz DE |